These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29196977)

  • 1. Self-Organized Cerebellar Tissue from Human Pluripotent Stem Cells and Disease Modeling with Patient-Derived iPSCs.
    Muguruma K
    Cerebellum; 2018 Feb; 17(1):37-41. PubMed ID: 29196977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs.
    Ishida Y; Kawakami H; Kitajima H; Nishiyama A; Sasai Y; Inoue H; Muguruma K
    Cell Rep; 2016 Nov; 17(6):1482-1490. PubMed ID: 27806289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D Culture for Self-Formation of the Cerebellum from Human Pluripotent Stem Cells Through Induction of the Isthmic Organizer.
    Muguruma K
    Methods Mol Biol; 2017; 1597():31-41. PubMed ID: 28361308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
    Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
    Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.
    Watson LM; Wong MM; Becker EB
    Open Biol; 2015 Jul; 5(7):150056. PubMed ID: 26136256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Simplified Method for Generating Purkinje Cells from Human-Induced Pluripotent Stem Cells.
    Watson LM; Wong MMK; Vowles J; Cowley SA; Becker EBE
    Cerebellum; 2018 Aug; 17(4):419-427. PubMed ID: 29397531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
    Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
    Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scalable Generation of Mature Cerebellar Organoids from Human Pluripotent Stem Cells and Characterization by Immunostaining.
    Silva TP; Fernandes TG; Nogueira DES; Rodrigues CAV; Bekman EP; Hashimura Y; Jung S; Lee B; Carmo-Fonseca M; Cabral JMS
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32597849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells.
    Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG
    Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.
    Montgomery A; Wong A; Gabers N; Willerth SM
    Biomater Sci; 2015 Feb; 3(2):401-13. PubMed ID: 26218131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.
    Wang B; Jakus AE; Baptista PM; Soker S; Soto-Gutierrez A; Abecassis MM; Shah RN; Wertheim JA
    Stem Cells Transl Med; 2016 Sep; 5(9):1257-67. PubMed ID: 27421950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
    Yoshida Y; Yamanaka S
    Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances for using human induced-pluripotent stem cells as pain-in-a-dish models of neuropathic pain.
    Labau JIR; Andelic M; Faber CG; Waxman SG; Lauria G; Dib-Hajj SD
    Exp Neurol; 2022 Dec; 358():114223. PubMed ID: 36100046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
    Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
    N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differentiation of pluripotent stem cells into male germ cells: An update].
    Wang SY; Cui YG; Qin LJ
    Zhonghua Nan Ke Xue; 2017 May; 23(5):468-472. PubMed ID: 29717842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
    Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
    Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells.
    Hollmann EK; Bailey AK; Potharazu AV; Neely MD; Bowman AB; Lippmann ES
    Fluids Barriers CNS; 2017 Apr; 14(1):9. PubMed ID: 28407791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.